美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=INDOCIN
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称INDOCIN
申请号016059产品号001
活性成分INDOMETHACIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构IROKO PHARMACEUTICALS LLC
2药品名称INDOCIN
申请号016059产品号002
活性成分INDOMETHACIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构IROKO PHARMACEUTICALS LLC
3药品名称INDOCIN
申请号017814产品号001
活性成分INDOMETHACIN市场状态停止上市
剂型或给药途径SUPPOSITORY;RECTAL规格50MG
治疗等效代码参比药物
批准日期1984/08/13申请机构IROKO PHARMACEUTICALS LLC
4药品名称INDOCIN SR
申请号018185产品号001
活性成分INDOMETHACIN市场状态停止上市
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1982/02/23申请机构IROKO PHARMACEUTICALS LLC
5药品名称INDOCIN
申请号018332产品号001
活性成分INDOMETHACIN市场状态处方药
剂型或给药途径SUSPENSION;ORAL规格25MG/5ML
治疗等效代码参比药物
批准日期1985/10/10申请机构IROKO PHARMACEUTICALS LLC
6药品名称INDOCIN
申请号018878产品号001
活性成分INDOMETHACIN SODIUM市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 1MG BASE/VIAL
治疗等效代码AP参比药物
批准日期1985/01/30申请机构RECORDATI RARE DISEASES INC